Impact Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Impact Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$462K	Sell	922 -46	-5%	-$22.1K	0.13%	154
2026 Q1	$476K	Sell	968 -10	-1%	-$5.43K	0.14%	146
2025 Q4	$567K	Buy	978 +3	+0.3%	+$1.7K	0.17%	122
2025 Q3	$473K	Sell	975 -9	-0.9%	-$4.19K	0.14%	143
2025 Q2	$399K	Sell	984 -40	-4%	-$16.7K	0.13%	165
2025 Q1	$510K	Buy	1,024 +70	+7%	+$37.9K	0.18%	132
2024 Q4	$496K	Buy	+954	New	+$525K	0.18%	135

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Impact Capital Partners's TMO Position: Q2 2026 in Review

Impact Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 4.8% in Q2 2026, selling an estimated $22.1K and leaving 922 shares worth $462K. The position accounts for 0.13% of the portfolio, ranked #154.

Impact Capital Partners first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $567K in Q4 2025. 627 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Impact Capital Partners held 922 shares of Thermo Fisher Scientific worth $462K as of Q2 2026.
Impact Capital Partners sold 46 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.1K.
Thermo Fisher Scientific made up 0.13% of Impact Capital Partners's portfolio in Q2 2026, its #154 holding.
Impact Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Impact Capital Partners's Thermo Fisher Scientific position peaked at $567K in Q4 2025.
627 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.